K. Pecankova

发表

Peripheral Blood Mononuclear Cell Proteome Changes in Patients with Myelodysplastic Syndrome

J. Čermák, K. Pecankova, P. Májek, 2015, BioMed research international.

Biosensor for Quantification of Fetuin-A as a Promising

D. Lós, K. Pecankova, P. Májek, 2018 .

N-Glycosylation of apolipoprotein A1 in cardiovascular diseases.

K. Pecankova, P. Májek, J. Dyr, 2015, Translational research : the journal of laboratory and clinical medicine.

Proteome Changes in the Plasma of Myelodysplastic Syndrome Patients with Refractory Anemia with Excess Blasts Subtype 2

J. Čermák, K. Pecankova, P. Májek, 2014, Disease markers.

Improved Coomassie Blue Dye-Based Fast Staining Protocol for Proteins Separated by SDS-PAGE

K. Pecankova, P. Májek, J. Dyr, 2013, PloS one.

The effect of the biological variability of samples on Coomassie blue dye based fast staining for SDS‐PAGE in nonfixed gels

K. Pecankova, P. Májek, J. Dyr, 2014, Electrophoresis.

Proteomic Case Studies of MDS in Progression: Heterogeneity and More Heterogeneity

J. Čermák, K. Pecankova, P. Májek, 2022, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Alpha-2-HS-glycoprotein plasma level decrease correlates with age in patients with myelodysplastic syndromes.

J. Čermák, K. Pecankova, P. Májek, 2017, Cancer biomarkers : section A of Disease markers.

Retinol binding protein 4 plasma level in myelodysplastic syndrome subgroups

J. Čermák, K. Pecankova, P. Májek, 2015, International journal of laboratory hematology.

Complement Activation Dramatically Accelerates Blood Plasma Fouling On Antifouling Poly(2-Hydroxyethyl Methacrylate) Brush Surfaces.

C. Rodriguez-Emmenegger, O. Pop-Georgievski, K. Pecankova, 2021, Macromolecular bioscience.

Extension of the Human Fibrinogen Database with Detailed Clinical Information—The αC-Connector Segment

Ž. Sovová, K. Pecankova, P. Májek, 2021, International journal of molecular sciences.

Proteome changes of plasma-derived extracellular vesicles in patients with myelodysplastic syndrome

E. Jäger, Ž. Sovová, J. Čermák, 2022, PloS one.

Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1

K. Pecankova, P. Májek, J. Dyr, 2011, Journal of Translational Medicine.

Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups

J. Čermák, K. Pecankova, P. Májek, 2015, BioMed research international.

SPR biosensor for quantification of fetuin-A as a promising multibiomarker.

K. Pecankova, P. Májek, F. Surman, 2018, Physiological research.

Mass spectrometry, data re-analysis, and homology modelling predict posttranslational modifications of leucine-rich alpha-2-glycoprotein as a marker of myelodysplastic syndrome.

Ž. Sovová, J. Čermák, K. Pecankova, 2022, Cancer biomarkers : section A of Disease markers.

Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients

J. Čermák, K. Pecankova, P. Májek, 2017, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome

J. Čermák, K. Pecankova, P. Májek, 2013, Proteome Science.

The Relation between Protein Adsorption and Hemocompatibility of Antifouling Polymer Brushes.

C. Rodriguez-Emmenegger, O. Pop-Georgievski, K. Pecankova, 2022, Macromolecular bioscience.

Research Article Peripheral Blood Mononuclear Cell Proteome Changes in Patients with Myelodysplastic Syndrome

J. Čermák, K. Pecankova, P. Májek, 2022 .